Dutch veterinarians order German autogenous vaccine against bluetongue

Published 2024년 4월 19일

Tridge summary

In the Netherlands, there's a growing interest among veterinary practices to import a German autogenous vaccine aimed at combating bluetongue serotype 3, a virus traced back to North Rhine-Westphalia, Germany. Reinard Everts, director of the Dutch sheep and goat breeders' organization NSFO, highlighted this trend. However, the Dutch Ministry of Agriculture, Nature and Food Quality, along with the Royal Dutch Society for Veterinary Medicine, maintains strict regulations against the widespread use of such vaccines. Concerns revolve around safety, efficacy, and the risk of contamination, limiting the vaccine's application to specific company cases within the country.

Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

Reinard Everts, director of the Dutch sheep and goat breeders' organization NSFO, thinks that there are dozens of veterinary practices that have ordered the German autogenous vaccine or are considering doing so. The Royal Dutch Society for Veterinary Medicine has also received signals about this. The autogenous vaccine is an inactivated vaccine based on a virus isolate obtained from a company in North Rhine-Westphalia where bluetongue serotype 3 had been diagnosed. The use of the vaccine in Germany is only permitted in the states of North Rhine-Westphalia and Lower Saxony. The use of an autogenous vaccine in the Netherlands is only permitted for a company-specific approach to animal diseases and not for broad application. There are risks associated with the use ...

Source: Agri Holland